Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), sold 93,726 shares at $45.80 ($4.3M) on 2019-01-18, disclosed to the SEC on 2019-01-22.
Open-market sale of $4.3M NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.80 | 33,219 | $1.5M | 35.4% |
| 2 | $45.80 | 33,219 | $1.5M | 35.4% |
| 3 | $46.16 | 13,644 | $630K | 14.6% |
| 4 | $46.16 | 13,644 | $630K | 14.6% |
| Total | $45.90 avg | 93,726 | $4.3M | 100% |
| Filing → |
| NVCR | SELL | 2021-04-15 | $38.5M | — | Filing → |
| NVCR | SELL | 2020-12-22 | $61.4M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |